Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003546450 | SCV004261261 | uncertain significance | not provided | 2023-12-09 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 251 of the A4GALT protein (p.Pro251Leu). This variant is present in population databases (rs28940571, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of A4GALT-related disorders (PMID: 10993874, 15142124, 20053607, 23927681). ClinVar contains an entry for this variant (Variation ID: 2693). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects A4GALT function (PMID: 10993874). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV003546450 | SCV005194504 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000002812 | SCV000022970 | affects | p phenotype | 2002-03-29 | no assertion criteria provided | literature only |